CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $152,000 | +47.6% | 38,010 | 0.0% | 0.88% | +99.3% |
| Q2 2020 | $103,000 | +28.8% | 38,010 | 0.0% | 0.44% | -52.9% |
| Q1 2020 | $80,000 | -61.4% | 38,010 | 0.0% | 0.94% | +81.9% |
| Q4 2019 | $207,000 | +81.6% | 38,010 | 0.0% | 0.51% | +102.4% |
| Q3 2019 | $114,000 | -89.3% | 38,010 | -86.7% | 0.25% | -75.6% |
| Q2 2019 | $1,065,000 | -7.0% | 284,869 | 0.0% | 1.04% | +11.9% |
| Q1 2019 | $1,145,000 | +9.6% | 284,869 | 0.0% | 0.93% | -21.9% |
| Q4 2018 | $1,045,000 | – | 284,869 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,910,000 | 1.84% |
| Novo Holdings A/S | 2,927,560 | $7,963,000 | 0.51% |
| Puissance Capital Management LP | 38,010 | $103,000 | 0.44% |
| CHI Advisors LLC | 364,132 | $990,000 | 0.39% |
| BVF INC/IL | 1,742,112 | $4,739,000 | 0.29% |
| Orbimed Advisors | 6,767,584 | $18,408,000 | 0.26% |
| EcoR1 Capital, LLC | 737,612 | $2,006,000 | 0.15% |
| Hikari Power Ltd | 60,959 | $166,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $364,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,192,742 | $3,244,000 | 0.00% |